Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial (Q33732575)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial (English)

1 reference

Europe PubMed Central

29 July 2017

phase I clinical trial

0 references

Maryalice Stetler-Stevenson

7

object named as

Maryalice Stetler-Stevenson

1 reference

Europe PubMed Central

29 July 2017

Seth M Steinberg

6

object named as

Seth M Steinberg

1 reference

Europe PubMed Central

29 July 2017

Robert J Kreitman

2

object named as

Robert J Kreitman

1 reference

Europe PubMed Central

29 July 2017

9

object named as

Ira Pastan

1 reference

Europe PubMed Central

29 July 2017

author name string

Alan S Wayne

1

1 reference

Europe PubMed Central

29 July 2017

Harry W Findley

3

1 reference

Europe PubMed Central

29 July 2017

Glen Lew

4

1 reference

Europe PubMed Central

29 July 2017

Cynthia Delbrook

5

1 reference

Europe PubMed Central

29 July 2017

David J Fitzgerald

8

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

9 March 2010

1 reference

Europe PubMed Central

29 July 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

29 July 2017

16

1 reference

Europe PubMed Central

29 July 2017

6

1 reference

Europe PubMed Central

29 July 2017

1894-1903

1 reference

Europe PubMed Central

29 July 2017

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Immunotoxin treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Chronic health conditions in adult survivors of childhood cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Childhood acute lymphoblastic leukaemia and relapse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Recombinant immunotoxins in the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Immunotoxins containing Pseudomonas exotoxin A: a short history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Effect of tumor necrosis factor-alpha on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

14 July 2018

Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

30 October 2018

Revised response criteria for malignant lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

30 October 2018

Immunotoxin therapy of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

30 October 2018

Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

30 October 2018

Recombinant RFB4 immunotoxins exhibit potent cytotoxic activity for CD22-bearing cells and tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840067

30 October 2018

Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress in the curative treatment of childhood hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardizing flow cytometry: a classification system of fluorescence standards used for flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20215554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-09-2980

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33732575&oldid=1993649249"